Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/10/058523
CTRI/2023/10/058523
Not yet recruiting
Phase 3

Pharmaceutical and comparitive clinical study of sudha parpati and shankha bhasma on mukha dooshika - nil

Dr.Shamja C Shamsudheen0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: - Health Condition 2: 3- AdministrationHealth Condition 3: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereHealth Condition 4: L988- Other specified disorders of the skin and subcutaneous tissue

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: 3- AdministrationHealth Condition 3: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereHealth Condition 4: L988- Other specified disorders of the skin and subcutaneous tissue
Sponsor
Dr.Shamja C Shamsudheen
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr.Shamja C Shamsudheen

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients irrespective of gender
  • •2\.Patients including teenagers with the age limit up to 30 yrs.

Exclusion Criteria

  • •1\.Patients having infected pidaka with ulcer, kushta
  • •2\.Pidaka erupting in places except mukha
  • •3\.Under any systemic disease or any concomitant medication like NSAIDs
  • •4\.Undertaking oral antibiotics within last one month

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
Clinical study of standardized shalmali ghrita wsr to Shweta Pradar (leucorrhoea)Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified
CTRI/2023/05/052248Shubhdeep ayurved medical college
Completed
Not Applicable
Clinical investigation of therapeutic effects of sorafenib on cutaneous angiosarcomaAngiosarcoma
JPRN-UMIN000017373Taku Fujimura2
Not yet recruiting
Not Applicable
Effectiveness of Navak Guggulu on obesity
CTRI/2023/03/051059Goverment Ayurvedic College, Patna
Completed
Phase 1
Efficacy and safety of Chinese herbal medicine (RCM-102) for treatment of seasonal allergic rhinitis (hayfever)seasonal allergic rhinitisInflammatory and Immune System - AllergiesRespiratory - Other respiratory disorders / diseasesAlternative and Complementary Medicine - Herbal remedies
ACTRN12612000209897Professor Charlie Xua104
Not yet recruiting
Not Applicable
To study the effect of â??Dashemani Kandughna Gelâ?? local application in the management of Dandruff ( itching over scalp, Flakes on scalp etc)Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
CTRI/2020/12/030010Dr Nilima Sanjay Dharkar